Get the Stockscreener App
2.12
4.43%
0.09
Cytomx Therapeutics Inc Stock (CTMX) Forecast
The Cytomx Therapeutics Inc (CTMX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.9958, representing a +41.31% increase from the current price of $2.12. The highest analyst price target is $4.1552, and the lowest is $1.8365.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTMX Price Target
Average 3.2975
(+55.54% Upside)
Is Cytomx Therapeutics Inc (CTMX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.88 | Neutral |
| STOCH(9,6) | 26.28 | Neutral |
| STOCHRSI(14) | 46.06 | Neutral |
| MACD(12,26) | -0.1099 | Sell |
| ADX(14) | 24.33 | Neutral |
| William %R | -71.73 | Neutral |
| CCI(14) | -71.26 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.0105
Sell
|
2.0211
Sell
|
| MA20 |
2.1663
Sell
|
2.119
Sell
|
| MA50 |
2.3192
Sell
|
2.1501
Sell
|
| MA100 |
1.8328
Buy
|
1.9223
Sell
|
| MA200 |
1.3645
Buy
|
1.6753
Buy
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, CTMX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on CTMX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.88 indicates that CTMX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.28 indicates that CTMX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.06 indicates that CTMX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.33 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -71.26 indicates that CTMX is still oversold but not to an extreme extent.
Long-term CTMX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cytomx Therapeutics Inc financial reports and earnings history, Cytomx Therapeutics Inc (CTMX) stock could reach $1.1298 by 2030, $8.7203 by 2040 and $16.94 by 2050. See the projected annual prices until 2050 of the Cytomx Therapeutics Inc stock below:
- Cytomx Therapeutics Inc (CTMX) is expected to reach an average price of $4.7118 in 2035, with a high prediction of $5.017 and a low estimate of $4.8518. This indicates an $122.25% rise from the last recorded price of $2.12.
- Cytomx Therapeutics Inc (CTMX) stock is projected to chart a bullish course in 2040, with an average price target of $8.5644, representing an $303.98% surge from its current level. The forecast ranges from a conservative $8.6114 to a sky-high $8.7203.
- Our analysts predict Cytomx Therapeutics Inc (CTMX) to jump 541.46% by 2045, soaring from $13.57 to an average price of $13.60, potentially reaching $13.53. While $13.57 is the low estimate, the potential upside is significant.
- Cytomx Therapeutics Inc (CTMX) stock is expected to climb by 2050, reaching an average of $17.30, a $715.88% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.94 and $16.84, respectively, highlighting the market's uncertainty.
Cytomx Therapeutics Inc Stock (CTMX) Year by Year Forecast
Cytomx Therapeutics Inc Stock (CTMX) Price Forecast for 2025
Cytomx Therapeutics Inc Stock (CTMX) is expected to reach an average price of $5.4333 in 2025, with a high prediction of $10.19 and a low estimate of $0.6773. This indicates an +156.29% rise from the last recorded price of $2.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $2.5171 | $1.8365 | $4.1552 | +18.73% |
| October, 2025 | $1.5104 | $1.2004 | $2.8078 | -28.75% |
| November, 2025 | $1.633 | $1.3611 | $2.5067 | -22.97% |
| December, 2025 | $1.6663 | $1.4037 | $2.235 | -21.40% |
Cytomx Therapeutics Inc Stock (CTMX) Price Forecast for 2026
The predicted value for Cytomx Therapeutics Inc (CTMX) in 2026 is set at an average of $2.7944. Estimates vary from a peak of $5.3946 to a trough of $0.1943, indicating an +31.81% surge from the present price of $2.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.5089 | $1.4569 | $2.9176 | +18.34% |
| February, 2026 | $2.9415 | $2.2009 | $3.1315 | +38.75% |
| March, 2026 | $3.1041 | $1.5935 | $3.5141 | +46.42% |
| April, 2026 | $4.1474 | $1.7148 | $4.6474 | +95.63% |
| May, 2026 | $3.54 | $2.2587 | $4.2981 | +66.98% |
| June, 2026 | $3.0327 | $2.5963 | $4.3707 | +43.05% |
| July, 2026 | $3.5259 | $1.8233 | $5.3946 | +66.32% |
| August, 2026 | $2.5685 | $2.0079 | $4.3266 | +21.16% |
| September, 2026 | $1.5318 | $1.2818 | $2.7192 | -27.74% |
| October, 2026 | $0.7444 | $0.7044 | $1.6225 | -64.88% |
| November, 2026 | $0.6671 | $0.1943 | $0.9251 | -68.53% |
| December, 2026 | $0.6903 | $0.389 | $1.0697 | -67.44% |
Cytomx Therapeutics Inc Stock (CTMX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cytomx Therapeutics Inc (CTMX) is $1.6601, with a high forecast of $3.2155 and a low forecast of $0.1047. This indicates an -21.69% decrease from the last price of $2.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0029 | $0.3816 | $1.0029 | -52.69% |
| February, 2027 | $3.0256 | $0.8326 | $3.2155 | +42.72% |
| March, 2027 | $2.1288 | $1.1632 | $3.156 | +0.42% |
| April, 2027 | $0.2685 | $0.1568 | $2.2595 | -87.33% |
| May, 2027 | $0.0841 | $0.1309 | $0.5491 | -96.03% |
| June, 2027 | $0.4126 | $0.1047 | $0.5647 | -80.54% |
| July, 2027 | $1.41 | $0.562 | $1.17 | -33.49% |
| August, 2027 | $2.0474 | $1.3987 | $1.7274 | -3.42% |
| September, 2027 | $2.3641 | $2.3218 | $2.3341 | +11.52% |
| October, 2027 | $2.3415 | $2.2422 | $2.3035 | +10.45% |
| November, 2027 | $2.5989 | $2.0696 | $1.9996 | +22.59% |
| December, 2027 | $2.1756 | $2.3306 | $2.3882 | +2.62% |
Cytomx Therapeutics Inc Stock (CTMX) Price Forecast for 2028
In 2028, Cytomx Therapeutics Inc (CTMX) is projected to reach an average price of $1.6466, with a high projection of $2.3758 and a low estimate of $0.9173. This indicates an -22.33% fall from the last price of $2.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.343 | $2.23 | $2.2687 | +10.52% |
| February, 2028 | $2.3104 | $2.2267 | $2.2504 | +8.98% |
| March, 2028 | $2.3971 | $2.3597 | $2.3371 | +13.07% |
| April, 2028 | $1.8545 | $2.0445 | $2.3758 | -12.52% |
| May, 2028 | $2.0612 | $1.9882 | $2.0312 | -2.77% |
| June, 2028 | $1.0486 | $1.1186 | $1.9906 | -50.54% |
| July, 2028 | $0.986 | $0.9173 | $0.7973 | -53.49% |
| August, 2028 | $1.6127 | $1.2753 | $1.2834 | -23.93% |
| September, 2028 | $1.8701 | $1.6321 | $1.8601 | -11.79% |
| October, 2028 | $1.6875 | $1.7766 | $1.738 | -20.40% |
| November, 2028 | $1.6042 | $1.6412 | $1.6042 | -24.33% |
| December, 2028 | $1.5716 | $1.6536 | $1.7522 | -25.87% |
Cytomx Therapeutics Inc Stock (CTMX) Price Forecast for 2029
The 2029 price forecast for Cytomx Therapeutics Inc Stock (CTMX) is $1.5668 on average, with a high prediction of $3.1018 and a low estimate of $0.0318. This represents an -26.09% decrease from the previous price of $2.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.4983 | $1.4953 | $1.4683 | -29.32% |
| February, 2029 | $1.7357 | $1.5777 | $1.6557 | -18.13% |
| March, 2029 | $1.7731 | $1.6944 | $1.7231 | -16.36% |
| April, 2029 | $1.8605 | $1.8774 | $1.8111 | -12.24% |
| May, 2029 | $1.8872 | $1.8898 | $1.9385 | -10.98% |
| June, 2029 | $1.6046 | $1.6546 | $1.7165 | -24.31% |
| July, 2029 | $1.422 | $1.522 | $1.5226 | -32.93% |
| August, 2029 | $1.3887 | $1.36 | $1.2793 | -34.50% |
| September, 2029 | $1.3761 | $1.4461 | $1.3683 | -35.09% |
| October, 2029 | $0.7128 | $0.4041 | $0.5128 | -66.38% |
| November, 2029 | $1.1102 | $0.7515 | $0.6402 | -47.63% |
| December, 2029 | $0.74 | $0.0318 | $3.1018 | -65.09% |
Cytomx Therapeutics Inc Stock (CTMX) Price Forecast for 2030
Cytomx Therapeutics Inc Stock (CTMX) is expected to reach an average price of $2.7069 in 2030, with a high forecast of $5.3607 and a low forecast of $0.0531. This signifies an +27.68% surge from the last price of $2.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1585 | $1.2387 | $1.1298 | -45.36% |
| February, 2030 | $0.2018 | $0.6895 | $1.0118 | -90.48% |
| March, 2030 | $1.383 | $0.0531 | $0.933 | -34.77% |
| April, 2030 | $2.6277 | $1.7717 | $2.2777 | +23.95% |
| May, 2030 | $3.8912 | $2.5138 | $3.4912 | +83.55% |
| June, 2030 | $4.851 | $3.9799 | $3.956 | +128.82% |
| July, 2030 | $5.2344 | $5.0133 | $5.3607 | +146.91% |
| August, 2030 | $2.1342 | $3.8659 | $4.7381 | +0.67% |
| September, 2030 | $3.0189 | $2.5729 | $2.6489 | +42.40% |
| October, 2030 | $3.6924 | $3.4937 | $3.3024 | +74.17% |
| November, 2030 | $5.6272 | $3.8611 | $3.8372 | +165.43% |
| December, 2030 | $3.2519 | $3.6219 | $5.2159 | +53.39% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):